GLP
Published on 24 Oct 2024 · source: MHRA — Medicines and Healthcare products Regulatory Agency
What this means
Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.
Summary
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).
